DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Levolet is a drug marketed by Genus Lifesciences and is included in one NDA.
The generic ingredient in LEVOLET is levothyroxine sodium. There are ten drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
A generic version of LEVOLET was approved as levothyroxine sodium by MYLAN on June 5th, 2002.
Recent Clinical Trials for LEVOLET
Identify potential brand extensions & 505(b)(2) entrants
|Dr. Reddy's Laboratories Limited||Phase 4|
|Dr. Reddy's Laboratories Limited||N/A|